Harvard Bioscience (HBIO) Stock: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$8.49
0.15 (1.80%)
▲
5d:
+4.17%
30d:
+7.2%
90d:
+37.16%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HBIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HBIO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.13
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.67
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $8.49, which is considered extended relative to its 30-day fair value range of $7.96 to $8.34. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.2) compared to its historical average (10.1). At these levels, the market is pricing in 9.3% annual earnings growth.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $7.90, while resistance sits at $8.80.
Market Sentiment: HBIO scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $7.50. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $7.90, while resistance sits at $8.80.
Market Sentiment: HBIO scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $7.50. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.96 -
$8.34
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.4%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (37/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 11.7% above Wall St target ($7.50)
- BULLISH: Expecting earnings turnaround to 9.3% growth with 11.1% revenue growth
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.96 -
$8.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.90
Resistance Level
$8.80
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.16
Wall Street Target
$7.50
(-11.7%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
-80.3%
Profit Margin
-11.9%
Valuation Premium vs History
+9.3% premium
PE vs Historical
13.2 vs 10.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.3%
(market-implied from PE analysis)
1-Year Target
$9.28
(+9%)
2-Year Target
$10.14
(+20%)
3-Year Target
$11.09
(+31%)
3-Yr Target (if PE normalizes)
(PE: 13→10)
PE COMPRESSION
$8.51
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 22, 2026 10:02 AM ET
Data refreshes hourly during market hours. Next update: 11:02 AM
Data refreshes hourly during market hours. Next update: 11:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 41 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 45 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 53 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 67 BUY |
